Impact of Sex and Diet on Mesolimbic Amylin Signaling for Energy Balance Control
Impact of Sex and Diet on Mesolimbic Amylin Signaling for Energy Balance Control
批准号:
9370728
负责人:
Elizabeth Genevieve Mietlicki-Baase
金额:
$7.98万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-07-17 至 2019-06-30
关键词:
AcuteAddressAffectAgonistAnimal ModelAutomobile DrivingAwardBehavioralBehavioral MechanismsBody WeightBody Weight decreasedBrainCalcitonin ReceptorCell NucleusCellsCharacteristicsChronicComplementCost of IllnessDataDevelopmentDietDiseaseEatingEstrogen Receptor alphaEstrogen Receptor betaEstrogen ReceptorsEstrogensEstrusFeeding behaviorsFemaleFoodFutureGoalsHealthHigh Fat DietHormonesHumanHypothalamic structureImmunohistochemistryIn Situ HybridizationInjectableInjection of therapeutic agentIntakeKnowledgeLateralLigandsLightLiteratureMaintenanceMeasuresMediatingMentored Research Scientist Development AwardMethodsMotivationNeuraxisNeuroanatomyNeurobiologyNeuronsObesityPalatePharmacological TreatmentPharmacologyPharmacotherapyPhenotypePhysiologicalRattusReceptor ActivationReceptor SignalingResearchRewardsRoleSatiationSex CharacteristicsSignal TransductionSiteSourceSystemTechniquesTestingVentral Tegmental AreaWeightWeight Gainamylin receptorbasebehavioral pharmacologydesigndesigner receptors exclusively activated by designer drugsenergy balanceexperimental studyfeedingfollow-upin vivoinnovationinsightislet amyloid polypeptideknock-downmalemotivated behaviorneural circuitneuroregulationnovelobesity treatmentresponsesex
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract
Obesity is a highly prevalent and costly disease, but effective and non-invasive treatment options are
severely limited. The amylin system is considered a promising candidate for the development of novel anti-
obesity pharmacotherapies, as amylin agonists decrease food intake and produce weight loss in humans and
animal models. The ventral tegmental area (VTA), a mesolimbic nucleus with critical roles in feeding and
motivated behavior, is a physiologically and pharmacologically relevant site of action for the energy balance
effects of amylin. However, the mechanisms underlying VTA amylin receptor-mediated hypophagia remain
unresolved. In particular, the impacts of key variables like sex and diet on the ability of VTA amylin receptor
activation to promote negative energy balance are unknown. The overarching goal of this proposal is to
identify novel neuroanatomical and behavioral mechanisms by which VTA amylin receptor signaling
promotes hypophagia and weight loss, with particular focus on the role of sex and diet in these effects.
This award will facilitate the applicant's advancement toward becoming a fully independent PI by
exploring new topics in mesolimbic amylin signaling and generating crucial preliminary data for a
future R01 application. Specific Aim I uses an innovative combination of virogenetics and behavioral
pharmacology to test whether stimulation of VTA-projecting neurons in the lateral hypothalamus, a central
source of amylin, activates VTA amylin receptors to control energy balance. This will expand our knowledge by
investigating the inputs to VTA amylin receptors, and will provide insight into sex and diet differences by testing
male and female rats maintained on chow or high-fat diet (HFD). Specific Aim II evaluates the physiological
relevance of VTA amylin receptors for long-term energy balance control in females by testing the feeding and
body weight effects of VTA amylin receptor knockdown. This Aim also examines the phenotype of VTA amylin
receptor-expressing cells in females with a combination of immunohistochemistry and in situ hybridization. The
studies described in this application build upon the applicant's current K01 award by investigating the neural
circuits and behavioral mechanisms by which VTA amylin receptor signaling controls energy balance, and by
addressing dietary influences (e.g., palatable HFD or bland chow) on the VTA amylin system. These studies
are also distinct from the aims of the K01 by exploring a novel and important topic: the role of sex differences
in mesolimbic amylin signaling. These studies are designed to produce informative data that will serve as a
generative starting point for follow-up questions to be addressed in an R01 application. The novel combination
of in vivo and ex vivo techniques used in the proposed studies will further our understanding of the distributed
actions of amylin in the brain for energy balance control, filling important gaps in our scientific knowledge that
may further the development of novel amylin-based pharmacotherapies for the treatment of obesity.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Effects of mesolimbic amylin signaling on macronutrient intake
-
批准号:10530695
-
项目类别:
-
资助金额:$44.21万
-
财政年份:2021
-
负责人:Elizabeth Genevieve Mietlicki-Baase
-
依托单位:
Effects of mesolimbic amylin signaling on macronutrient intake
-
批准号:10365862
-
项目类别:
-
资助金额:$36.02万
-
财政年份:2021
-
负责人:Elizabeth Genevieve Mietlicki-Baase
-
依托单位:
Amylin-mediated control of energy balance in the mesolimbic reward system
-
批准号:8804585
-
项目类别:
-
资助金额:$15.51万
-
财政年份:2014
-
负责人:Elizabeth Genevieve Mietlicki-Baase
-
依托单位:
Glucagon-like peptide-1 in brainstem integration of energy balance control
-
批准号:8525619
-
项目类别:
-
资助金额:$5.19万
-
财政年份:2013
-
负责人:Elizabeth Genevieve Mietlicki-Baase
-
依托单位:
Glucagon-like peptide-1 in brainstem integration of energy balance control
-
批准号:8639358
-
项目类别:
-
资助金额:$3.06万
-
财政年份:2013
-
负责人:Elizabeth Genevieve Mietlicki-Baase
-
依托单位:
海外基金